Related Experiment Video
Updated: Jan 10, 2026
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Development and validation of a clinical prediction model for coronary microcirculatory impairment post-PCI in STEMI
Hong-Kai Xiao1, Jing-Hu Liu, Qin-Hong Cai
1Department of Cardiology, The Fourth Affiliated Hospital, Guangzhou Medical University, Zengcheng District, Guangzhou, Guangdong Province, China.
Insights
This study developed a model to predict microvascular dysfunction after heart attack treatment. It uses simple blood tests and patient factors to identify high-risk patients early.
Area of Science:
- Cardiology
- Biomedical Engineering
- Clinical Prediction Modeling
Background:
- Microvascular dysfunction is a key factor in poor outcomes after ST-segment elevation myocardial infarction (STEMI) treatment, even with successful epicardial reperfusion.
- Current methods for assessing coronary microcirculatory disturbances (CMD) post-percutaneous coronary intervention (PCI) may not be universally applicable.
- There is a need for a clinically practical tool to predict CMD risk in STEMI patients undergoing PCI.
Purpose of the Study:
- To develop and validate a prediction model for coronary microcirculatory disturbances (CMD) in STEMI patients post-primary PCI.
- To identify key clinical and biochemical predictors of CMD.
- To provide a tool for early risk stratification and guide post-PCI management.
Main Methods:
- Retrospective analysis of 104 STEMI patients treated with emergency PCI.
- Categorization into CMD and non-CMD groups based on echocardiographic assessment within 24 hours post-PCI.
- Multivariate logistic regression to identify predictors and build a prediction model, validated in an 80-patient cohort.
Main Results:
- Elevated lactate, serum creatinine, and high-sensitivity C-reactive protein were significant predictors of CMD.
- Older age, hypertension, diabetes, prolonged ischemic time, and coronary slow-flow also predicted CMD.
- The logistic model showed high predictive accuracy (AUC=0.903) and performed well in validation (AUC=0.868).
Conclusions:
- A multivariable prediction model using biochemical markers (lactate, creatinine, hs-CRP) and clinical factors can reliably identify STEMI patients at risk for CMD post-PCI.
- This model offers early risk stratification for CMD.
- The tool can aid in tailoring post-revascularization strategies to improve outcomes.
Abstract:
Microvascular dysfunction following primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) remains a significant determinant of poor prognosis, despite successful epicardial reperfusion. This study aimed to establish a clinically applicable prediction model to assess the risk of coronary microcirculatory disturbances (CMD) using arterial lactate, serum creatinine, and high-sensitivity C-reactive protein levels. A retrospective analysis was conducted on 104 STEMI patients treated with emergency PCI. Patients were categorized into CMD and non-CMD groups based on echocardiographic microvascular perfusion assessment within 24 hours post-intervention. Multivariate logistic regression was applied to identify independent predictors and build a diagnostic model, which was validated using a separate cohort (n = 80). Model performance was evaluated using receiver operating characteristic curves and the Hosmer-Lemeshow goodness-of-fit test. Elevated levels of lactate (>2.620 mmol/L), serum creatinine (>113.760 μmol/L), and high-sensitivity C-reactive protein (>9.310 mg/L), along with older age, hypertension, diabetes, prolonged ischemic time, and coronary slow-flow were identified as independent predictors of CMD. The derived logistic model demonstrated high predictive accuracy (AUC = 0.903), with robust performance in the external validation cohort (AUC = 0.868). A multivariable prediction model incorporating biochemical and clinical indicators offers reliable early identification of CMD risk in STEMI patients after PCI. This tool may guide tailored post-revascularization management strategies aimed at improving myocardial perfusion and patient outcomes.
